Dexco (B3: DXCO3) financial statements
The consolidated income statement, balance sheet and cash flow statement of Dexco for its last 10 fiscal years, as filed with the regulator, in millions of Brazilian reais. At the end of fiscal 2025 it had BRL 19,001m in total assets and BRL 6,847m in equity.
Income statement
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | BRL 8,249m | BRL 8,235m | BRL 7,383m | BRL 8,487m | BRL 8,170m | BRL 5,880m | BRL 5,012m | BRL 4,949m | BRL 3,991m | BRL 3,910m |
| Cost of sales | BRL 6,239m | BRL 5,783m | BRL 5,008m | BRL 5,615m | BRL 5,300m | BRL 4,028m | BRL 3,718m | BRL 3,651m | BRL 2,847m | BRL 2,901m |
| Gross profit | BRL 2,010m | BRL 2,452m | BRL 2,376m | BRL 2,872m | BRL 2,870m | BRL 1,852m | BRL 1,294m | BRL 1,299m | BRL 1,144m | BRL 1,009m |
| Operating profit | BRL 740.3m | BRL 936.5m | BRL 1,270m | BRL 1,449m | BRL 1,891m | BRL 671.9m | BRL 639.4m | BRL 732.7m | BRL 421.3m | BRL 317.1m |
| Profit before tax | −BRL 88.2m | BRL 344.5m | BRL 751.2m | BRL 917.5m | BRL 1,989m | BRL 534.7m | BRL 479.0m | BRL 582.4m | BRL 215.2m | BRL 17.8m |
| Income tax | −BRL 151.3m | BRL 170.1m | −BRL 60.0m | BRL 152.6m | BRL 263.4m | BRL 80.8m | BRL 73.3m | BRL 150.6m | BRL 30.2m | −BRL 8.4m |
| Net profit | BRL 1.2m | BRL 172.4m | BRL 789.6m | BRL 755.9m | BRL 1,725m | BRL 453.8m | BRL 405.6m | BRL 431.6m | BRL 184.9m | BRL 23.6m |
Balance sheet
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | BRL 19,001m | BRL 18,144m | BRL 17,921m | BRL 15,625m | BRL 13,420m | BRL 11,499m | BRL 10,715m | BRL 9,622m | BRL 9,466m | BRL 9,341m |
| Current assets | BRL 6,048m | BRL 5,066m | BRL 5,761m | BRL 5,174m | BRL 4,661m | BRL 4,220m | BRL 3,514m | BRL 3,652m | BRL 3,023m | BRL 3,215m |
| Cash | BRL 2,178m | BRL 1,231m | BRL 2,785m | BRL 1,772m | BRL 1,421m | BRL 1,728m | BRL 1,243m | BRL 1,162m | BRL 1,074m | BRL 1,416m |
| Total liabilities | BRL 11,793m | BRL 10,949m | BRL 11,399m | BRL 9,663m | BRL 7,685m | BRL 6,310m | BRL 5,783m | BRL 4,987m | BRL 4,749m | BRL 4,770m |
| Current liabilities | BRL 2,701m | BRL 3,642m | BRL 3,609m | BRL 3,265m | BRL 3,372m | BRL 2,412m | BRL 2,150m | BRL 2,073m | BRL 1,552m | BRL 1,197m |
| Equity | BRL 6,847m | BRL 6,977m | BRL 6,404m | BRL 5,872m | BRL 5,734m | BRL 5,187m | BRL 4,931m | BRL 4,634m | BRL 4,715m | BRL 4,570m |
| Equity including minorities | BRL 7,208m | BRL 7,195m | BRL 6,522m | BRL 5,962m | BRL 5,735m | BRL 5,188m | BRL 4,932m | BRL 4,635m | BRL 4,716m | BRL 4,571m |
| Minority interests | BRL 361.2m | BRL 218.2m | BRL 118.5m | BRL 89.2m | BRL 1.3m | BRL 1.5m | BRL 1.3m | BRL 1.2m | BRL 1.0m | BRL 1.1m |
Cash flow statement
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | BRL 850.6m | BRL 1,284m | BRL 1,346m | BRL 793.7m | BRL 1,708m | BRL 1,508m | BRL 1,108m | BRL 382.9m | BRL 404.7m | BRL 450.6m |
| Investing cash flow | −BRL 770.0m | −BRL 1,981m | −BRL 1,303m | −BRL 1,638m | −BRL 1,069m | −BRL 965.7m | −BRL 263.0m | BRL 24.0m | −BRL 416.2m | −BRL 473.7m |
| Financing cash flow | BRL 859.0m | −BRL 882.6m | BRL 960.5m | BRL 1,227m | −BRL 942.4m | −BRL 68.6m | −BRL 766.0m | −BRL 323.0m | −BRL 331.9m | BRL 536.3m |
| Dividends paid | −BRL 45.5m | −BRL 233.9m | −BRL 248.8m | −BRL 0.1m | −BRL 1,394m | −BRL 257.3m | −BRL 545.8m | −BRL 60.8m | −BRL 6.1m | −BRL 105.5m |
Where each figure comes from
From the annual financial statements (DFP) that Dexco files with the CVM, the Brazilian securities regulator. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. If an item is not tagged in the filing, it is not in the table. The summary of the last fiscal year is on the Dexco page.
More companies from Brazil and the rest of the region: Latin American stocks.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.